Abstract
The pediatric population displays its own pharmacological characteristics, making children vulnerable to adverse drug reactions (ADRs). To determine the incidence of ADRs among the pediatric emergency department (PED) population. This is a descriptive, noncontrolled, prospective, and single-center study, during 4 consecutive months in the PED of Nantes University Hospital. Setting up active gathering of data on ADRs enabled 121 reports of 11 095 consultations at the emergency department, which corresponds to an ADR incidence of 1.09%. Digestive and cutaneous reactions made up the majority of reactions judged as being nonserious (53%) and were mainly found in children between 2 -11 years old. Of the serious ADRs, 25% were found in the 12-15-year-old age range because of the drug overdose. The main medications administered, which were responsible for the majority of the ADRs, were an equimolar mix of oxygen and nitrogen monoxide, amoxicillin, and acetaminophen. Three means of collecting data were possible: collecting files data, oral communication, or filling a form, the last being the most used method. This active data gathering shows the incidence and nature of the adverse effects as well as the age distribution in the PED popu...Continue Reading
References
Jan 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·K HawtonH Weitzel
Mar 19, 1999·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·E G BrownS Wood
May 23, 2000·Lancet·G Menniti-IppolitoL Cantarutti
Jul 17, 2001·British Journal of Clinical Pharmacology·P ImpicciatoreM Bonati
Aug 8, 2002·Pediatrics·Jutta WeissWolfgang Rascher
Jun 3, 2005·Thérapie·Pascale OlivierMaryse Lapeyr-Mestre
Jun 14, 2005·British Journal of Clinical Pharmacology·Derek StewartJames McLay
Nov 25, 2005·British Journal of Clinical Pharmacology·A VallanoJ M Arnau
Jun 3, 2006·Pediatrics·Reese H ClarkDale R Gerstmann
Aug 3, 2006·Pediatrics·Jennifer LeJane Hodding
Oct 20, 2006·Clinical Pharmacokinetics·Imke H BartelinkJohn N van den Anker
Jan 2, 2009·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·F PlanchampUNKNOWN Groupe de travail pharmacovigilance en pédiatrie
Jun 18, 2009·Archives of Disease in Childhood·A Clavenna, M Bonati
Sep 30, 2009·Pediatrics·Florence T BourgeoisMichael W Shannon
Feb 6, 2010·Archives of Disease in Childhood·Maisoon Abdullah GhalebIan Chi Kei Wong
Dec 22, 2011·Thérapie·UNKNOWN Cercle de Reflexion sur l'ImputabiliteMarie-Blanche Valnet-Rabier
Mar 10, 2012·PloS One·Rebecca Mary Diane SmythPaula Williamson
Jul 4, 2012·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·E Autret-LecaA-P Jonville-Béra
Nov 1, 2011·Thérapie·UNKNOWN Cercle de Réflexion sur l’Imputabilité (CRI)Marie-Blanche Valnet-Rabier
Citations
Jan 31, 2016·The Annals of Pharmacotherapy·Xiulu RuanAlan David Kaye
Oct 31, 2018·European Journal of Pediatrics·Carla CarnovaleSonia Radice
Mar 23, 2019·International Journal of Nursing Knowledge·Vanessa Monteiro MantovaniEneida Rejane Rabelo-Silva
Aug 3, 2017·Paediatric Drugs·Geneviève DurrieuJean-Louis Montastruc
May 21, 2020·Pharmacoepidemiology and Drug Safety·Malahat KhaliliAli Akbar Haghdoost
Sep 22, 2016·SpringerPlus·Hyun Jeong BaekDong In Suh
Jan 31, 2019·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Jennifer G KendrickRoxane R Carr